$ADTX Dr. Drew, a practicing physician, internist, and an addiction medicine specialist, will advise on the development of AditxtScore™ platform, and its various potential applications including possibly scoring immunity to COVID-19 and other infectious diseases, as well as autoimmune disorders such as Type I Diabetes. Amro Albanna, Co-Founder and Chief Executive Officer of Aditxt, stated, “Dr. Drew is a key addition to our leadership team and I am very proud that he will become a part of our journey. I believe Dr. Drew’s scientific, medical, and media background will make him a great fit for executing our vision for AditxtScore. With today’s announcement and the ones we recently made, I believe the MARKET WILL BEGIN TO SEE how we are laying a STRONG FOUNDATION necessary for commercializing our therapeutics as well as our immune monitoring biotechnologies.” Dr. Pinsky added,“I believe that the AditxtScore platform could be game changing."
  • 2